About this document "Clinical exam & history": how does this work
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Let me explain this clinical exam & history document specifically for follicular lymphoma monitoring, based on the provided information:
According to the NCCN Guidelines for Follicular Lymphoma (2025), this clinical exam and history involves:
Frequency:
- Every 3-6 months for the first 2 years
- Then transitions to every 6-12 months afterward
Key Features:
- Purpose: The document shows this exam is specifically designed to:
- Detect symptomatic relapse
- Monitor for possible transformation of the lymphoma
According to the Leukemia & Lymphoma Society guidelines, clinical exams for lymphoma typically include:
- Physical examination of lymph nodes and organs
- Discussion of any new symptoms
- Review of patient's medical history and current health status
Important Practical Details:
- Turnaround Time: Results are immediate during the visit
- Insurance Coverage: Yes, this monitoring exam is covered
- No specific price is listed as it varies by provider/location
IMPORTANT NOTE: As specified in NCCN Guidelines, these regular clinical exams are a crucial part of the monitoring phase for follicular lymphoma patients. However, I strongly recommend discussing your specific monitoring schedule with your healthcare team, as they may adjust the frequency based on your individual circumstances.
Sources:
- NCCN Guidelines for Follicular Lymphoma 2025 (as cited in document)
- Leukemia & Lymphoma Society monitoring guidelines
- ASCO Guidelines for Lymphoma Surveillance
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ